Literature DB >> 19665241

Prevalence of hypomagnesemia (HM) in a geriatric long-term care (LTC) setting.

Zeev Arinzon1, Alexander Peisakh, Samuel Schrire, Yitshal Neor Berner.   

Abstract

Electrolyte abnormalities are frequently observed in elderly long-term care (LTC) patients. Magnesium is a trace mineral, but is the second most abundant intracellular cation and the fourth most abundant cation in the body. This was a cross-sectional study to assess the prevalence of hypomagnesemia (HM) in non-selected elderly LTC patients. A total of 159 patients aged 65 years and older were included in the study. The attributes and variables related to the patients' hospital course were used to compare the two groups. We used univariate and multivariate analyses to correlate magnesium levels with demographic, clinical factors and laboratory data. HM was found in 36% of the patients, of whom 35% presented with moderate HM (0.8-0.9 microequiv./l) and 18% with severe HM (<or=0.7 microequiv./l). Patients with HM had a higher number of comorbid diseases per patient (p=0.038), low body mass index (BMI) (p=0.044) and more of them presented with laboratory markers of malnutrition, such as low total cholesterol (TC) and serum albumin (SA) levels. Coexistence with other electrolyte abnormalities was higher among patients with HM than without (p=0.006), predominantly hypocalcemia and hypokalemia (p=0.023 and 0.032, respectively). Using regression analysis, independent variables significantly associated with serum magnesium levels were serum albumin, calcium, potassium, urea levels, chronic renal failure (CRF), chronic heart failure (CHF), diabetes mellitus (DM) and diuretic drugs (R(2)=0.877). Both early (up to 30 days) and late rate of death were higher in patients with HM. The incidence of HM in LTC elderly patients is high and multifactorial. Understanding the causes of HM, correction of magnesium level, and definitive and effective treatment of the cause leading to HM is important to improve patient prognosis. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665241     DOI: 10.1016/j.archger.2009.07.002

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  4 in total

1.  A case of hypocalcemia.

Authors:  Nicola Veronese; Francesco Bolzetta; Marco Mosele; Enzo Manzato; Giuseppe Sergi
Journal:  Intern Emerg Med       Date:  2011-03-03       Impact factor: 3.397

2.  Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Pamela L Lutsey; Alvaro Alonso; Erin D Michos; Laura R Loehr; Brad C Astor; Josef Coresh; Aaron R Folsom
Journal:  Am J Clin Nutr       Date:  2014-07-16       Impact factor: 7.045

3.  Calcium, magnesium and potassium intake and mortality in women with heart failure: the Women's Health Initiative.

Authors:  Emily B Levitan; James M Shikany; Ali Ahmed; Linda G Snetselaar; Lisa W Martin; J David Curb; Cora E Lewis
Journal:  Br J Nutr       Date:  2012-11-19       Impact factor: 3.718

Review 4.  The relevance of magnesium homeostasis in COVID-19.

Authors:  Valentina Trapani; Andrea Rosanoff; Shadi Baniasadi; Mario Barbagallo; Sara Castiglioni; Fernando Guerrero-Romero; Stefano Iotti; André Mazur; Oliver Micke; Guitti Pourdowlat; Giuliana Scarpati; Federica I Wolf; Jeanette A Maier
Journal:  Eur J Nutr       Date:  2021-10-23       Impact factor: 5.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.